A Fatal Adverse Effect of Barbiturate Coma Therapy: Dyskalemia / 대한신경손상학회지
Korean Journal of Neurotrauma
; : 156-158, 2016.
Article
en En
| WPRIM
| ID: wpr-122136
Biblioteca responsable:
WPRO
ABSTRACT
The management guideline for traumatic brain injury (TBI) recommends high-dose barbiturate therapy to control increased intracranial pressure refractory to other therapeutic options. High-dose barbiturate therapy, however, may cause many severe side effects; the commonly recognized ones include hypotension, immunosuppression, hepatic dysfunction, renal dysfunction, and prolonged decrease of cortical activity. Meanwhile, dyskalemia remains relatively uncommon. In this study, we report the case of a hypokalemic patient with severe rebound hyperkalemia, which occurred as a result of barbiturate coma therapy administered for TBI treatment.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Lesiones Encefálicas
/
Presión Intracraneal
/
Terapia de Inmunosupresión
/
Coma
/
Hiperpotasemia
/
Hipopotasemia
/
Hipotensión
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Korean Journal of Neurotrauma
Año:
2016
Tipo del documento:
Article